Merck (MRK)-Update
Merck has successfully validated our expectation of building its local bottom and followed our exoectation into our previusly defined Fibonacci
Read analysis
Elliott Wave Analyses
Health & Biotech
From pharmaceutical giants and health insurers to cutting-edge biotech and gene-editing pioneers — this sector tracks the companies advancing human health and medicine.
Hims & Hers Health (HIMS) - Update
2 out of 2 — this analysis has once again been a major success. We are now officially deactivating our second
Read analysis
Tilray Brands (TLRY) - Update
This was a clear success — we are now officially deactivating our defined Fibonacci buying zone. The chart shown at the
Read analysis
Canopy Growth (CGC)-Update
This worked out perfectly. In our previous analysis, Canopy Growth reached and activated our defined Fibonacci retracement zone, which we
Read analysis
Hims & Hers Update
Hims & Hers has activated our Fibonacci buying zone In our previous analysis update, we defined a Fibonacci retracement zone
Read analysis
Tilray Brands (TLRY)
Tilray has now entered and activated our Fibonacci buying zone. In our previous analysis from March 5th, 2026, we outlined
Read analysisWant to follow the latest analyses?
Join free to explore Elliott Wave breakdowns and the public performance tracker.